SCHEMBL3519277

SCHEMBL3519277

CCN1C(=O)C(C)(C)C(=O)N(C)c2ccc(O)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.42
GPR55 Q9Y2T6 2/20 0.42
PKM P14618 2/20 0.39
GAA P10253 1/20 0.38
DYRK3 O43781 1/20 0.37
CSNK1E P49674 1/20 0.37
CLK1 P49759 1/20 0.37
CLK2 P49760 1/20 0.37
CLK3 P49761 1/20 0.37
GSK3B P49841 1/20 0.37
DYRK1A Q13627 1/20 0.37
DYRK2 Q92630 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
DYRK4 Q9NR20 1/20 0.37
DYRK1B Q9Y463 1/20 0.37
KCNA5 P22460 10/20 0.37
KCNJ5 P48544 9/20 0.37
KCNJ3 P48549 9/20 0.37
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3516991 0.94 CNR1 (0.42) CNR1GPR55PKMGAADYRK3
SCHEMBL3521032 0.91 CNR1 (0.46) CNR1GPR55PKMGAADYRK3
SCHEMBL3515695 0.86 PKM (0.45) CNR1GPR55PKMGAAOPRD1
SCHEMBL3518167 0.84 KCNA5 (0.40) CNR1GPR55PKMGAAKCNA5
SCHEMBL9893333 0.82 CNR1 (0.39) CNR1GPR55PKMDYRK3CSNK1E
SCHEMBL9893261 0.82 MEN1 (0.41) CNR1GPR55PKMGAAKCNA5
SCHEMBL3516032 0.80 GAA (0.41) CNR1GPR55PKMGAADYRK3
SCHEMBL3520270 0.80 KCNA5 (0.43) GAAKCNA5KCNJ5KCNJ3OPRL1
SCHEMBL3515688 0.79 EP300 (0.37) CNR1GPR55PKMGAAKCNA5
Hydrochloric Acid SCHEMBL9960363 0.78 ELANE (0.46) CNR1GPR55PKMKCNA5KCNJ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664217-B2 Benzodiazepine compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2014-03-04 US disclosed
US-20130040941-A1 BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. 2013-02-14 US disclosed
US-8338406-B2 Benzodiazepine compound and pharmaceutical composition OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-12-25 US disclosed
US-20100331317-A1 BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100331317-A1 BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION KCNA5, KCNA1, KCNAB1 CNR1 93/4885GPR55 167/4885PKM 638/4885
US-20130040941-A1 BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION KCNA5, KCNA1, KCNAB1 CNR1 93/4885GPR55 167/4885PKM 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.